What is Hansoh Pharmaceutical Group Co Days Payable?
Hansoh Pharmaceutical Group CoHNSPF 90 Days Payable is 65.17 as of Dec. 2025, which is 6% below its 10-year median of 69.36. GuruFocus rates HNSPF with a GF Score™ of 90/100 and a GF Value™ of $3.00 (Modestly Overvalued). Among 922 Drug Manufacturers companies, Hansoh Pharmaceutical Group Co ranks worse than 63.23% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hansoh Pharmaceutical Group Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Hansoh Pharmaceutical Group Co's Days Payable falls into.
Hansoh Pharmaceutical Group Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co (HNSPF) has a Days Payable of 65.17 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hansoh Pharmaceutical Group Co and its competitors. This is near median its historical median of 69.36. Over the past decade, Hansoh Pharmaceutical Group Co's Days Payable has ranged from 41.26 to 104.11. According to the industry distribution chart, Hansoh Pharmaceutical Group Co ranks #583 out of 922 companies in the Drug Manufacturers industry, placing it in the top 63.2%.
Is Hansoh Pharmaceutical Group Co's Days Payable too high?
Hansoh Pharmaceutical Group Co's current Days Payable of 65.17 is near median its 10-year median of 69.36. Over the past 10 years, this metric has ranged from a low of 41.26 to a high of 104.11. The Drug Manufacturers industry median Days Payable is 90.84. Hansoh Pharmaceutical Group Co's value of 65.17 is 28.3% below this industry median. Based on the distribution chart, Hansoh Pharmaceutical Group Co ranks #583 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hansoh Pharmaceutical Group Co has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hansoh Pharmaceutical Group Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hansoh Pharmaceutical Group Co ranks #583 out of 922 companies for Days Payable. This places Hansoh Pharmaceutical Group Co in the lower half of its industry. The industry median Days Payable is 90.84. Hansoh Pharmaceutical Group Co's value of 65.17 is 28.3% below this benchmark. Historically, Hansoh Pharmaceutical Group Co's own Days Payable has ranged from 41.26 to 104.11 over the past decade. While the company's 10-year median is 69.36 vs. the industry median of 90.84, Hansoh Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hansoh Pharmaceutical Group Co's current Days Payable of 65.17 is 28.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hansoh Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hansoh Pharmaceutical Group Co's current Days Payable is 65.17, which is near median its own 10-year median of 69.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hansoh Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co (HNSPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.00, compared to a current price of $3.83 — trading 27.5% above its estimated fair value. The current Days Payable is 65.17, which is near median its 10-year median of 69.36 and 28.3% below the Drug Manufacturers industry median of 90.84. Hansoh Pharmaceutical Group Co's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hansoh Pharmaceutical Group Co (HNSPF), the current Days Payable is 65.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hansoh Pharmaceutical Group Co (HNSPF) Overvalued in 2026?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of $3.83 is trading 27.5% above its estimated GF Value™ of $3.00.
GuruFocus considers Hansoh Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for HNSPF:
Days Payable: 65.17 (near median its 10-year median of 69.36)
GF Value™: $3.00 vs. price of $3.83 (27.5% above fair value)
Industry Position: 28.3% below the Drug Manufacturers median (#583 of 922)
No single metric tells the full story. See the HNSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hansoh Pharmaceutical Group Co Business Description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
90GF Score
Get the complete analysis for HNSPF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HNSPF has been successfully added to your 
